Stacy Robison, APRN
Nurse Practitioner · South Jordan, UTNPI 1346271798
Payments from drug & device makers
Across 153 payments — averaging $17.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$671
- Collegium Pharmaceutical, Inc.$394
- Lundbeck LLC$237
- Pfizer$202
- Indivior Inc.$178
- Amgen$120
- plus $914 from 19 others
What the payments were for
- Food & beverage$2,716100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 44 | $671 |
| Collegium Pharmaceutical, Inc. | 25 | $394 |
| Lundbeck LLC | 13 | $237 |
| Pfizer | 7 | $202 |
| Indivior Inc. | 8 | $178 |
| Amgen | 6 | $120 |
| Averitas Pharma Inc. | 3 | $110 |
| Teva Pharmaceuticals USA, Inc. | 7 | $109 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $86 |
| Virtus Pharmaceuticals LLC | 6 | $84 |
| Idorsia Pharmaceuticals US Inc | 4 | $69 |
| Medtronic | 1 | $53 |
| Lilly USA, LLC | 4 | $53 |
| Biodelivery Sciences International, Inc. | 4 | $48 |
| Arbor Pharmaceuticals, Inc. | 3 | $47 |
| Eisai Inc. | 2 | $36 |
| Globus Medical | 1 | $34 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $33 |
| Biohaven Pharmaceuticals, Inc. | 1 | $33 |
| Merck | 2 | $27 |
| Jazz Pharmaceuticals Inc. | 2 | $26 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Almatica Pharma LLC | 1 | $17 |
| Nevro Corp. | 1 | $16 |
| Redhill Biopharma Inc. | 1 | $12 |
How this compares
$2,716 in reported general payments places this provider in the 90th percentile of 979 nurse practitioner providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| UbrelvyUbrogepant | 17 | $16,093 |
| Xtampza ErOxycodone Myristate | 14 | $14,754 |
| Oxycodone Hcl | 511 | $11,586 |
| Emgality PenGalcanezumab-Gnlm | 13 | $8,619 |
| BelsomraSuvorexant | 11 | $4,758 |
| Buprenorphine Hcl | 64 | $4,023 |
| Morphine Sulfate ErMorphine Sulfate | 142 | $3,780 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 127 | $3,246 |
| Gabapentin | 131 | $2,353 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 77 | $2,254 |
| Tizanidine Hcl | 84 | $1,361 |
| Fentanyl | 16 | $1,187 |
| Morphine Sulfate | 40 | $856 |
| Pregabalin | 36 | $768 |
| Ibuprofen | 37 | $656 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieUbrelvy | $671 | $16,09317 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er | $394 | $14,75414 claims |
| MerckBelsomra | $27 | $4,75811 claims |
| Almatica Pharma LLCSertraline Hcl | $17 | $18012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 979 nurse practitioner providers in Utah.
Other nurse practitioner in South Jordan
- David GambleAmerican Fork$836K
- Julia BattenSalt Lake City$223K
- Stacie EganOgden$170K
- Traci AndreasonLehi$161K
- Geoffrey OsmondDraper$62K
- Trenton GraySouth Salt Lake$40K
- Kelsey FurrWest Jordan$21K
- Merin KinikiniSalt Lake City$19K
- Phillip BowmanSalt Lake City$18K
- Lynn LarsenOgden$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.